Biomarkers for Prediction of Tumor Response to Radiotherapy
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
Study of Avelumab-M3814 Combinations
- Status
- COMPLETED
- Phase
- PHASE1
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study to Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AML
- Status
- TERMINATED
- Phase
- PHASE1
The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy
- Status
- COMPLETED
- Phase
- PHASE2
An Expanded Access Program for AM0010 (Pegilodecakin)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study of RO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
- Status
- RECRUITING
- Phase
- PHASE3
Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of E7130 in Participants With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Dose-escalation Study of Subcutaneous ALM201 in Patients With Advanced Ovarian Cancer and Other Solid Tumours
- Status
- TERMINATED
- Phase
- PHASE1
A Study of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin) in Participants With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Investigate the Bioequivalence or Relative Bioavailability of Three New Idasanutlin Tablet Variants Following Oral Administration in Participants With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1